Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. Regarding Control Subsidiary Received Notice of Approval for Chemical Raw Material Drug Listing Application
Jinling Pharmaceutical: Announcement on the Resignation of Non-Employee Supervisors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement on the completion of industrial and commercial changes registration for capital increase of Jinling Pharmaceutical Co., Ltd., a wholly-owned subsidiary.
Jinling Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2023 Annual General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on completing the registration of industrial and commercial changes
Jinling Pharmaceutical: Internal Control Self-Assessment Report
Jinling Pharmaceutical: Special instructions for securities investment
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on increasing registered capital and amending the “Articles of Association”
Jinling Pharmaceutical: Rules of procedure for the special meeting of independent directors of Jinling Pharmaceutical Co., Ltd.
Jinling Pharmaceutical: Announcement on the progress of the company's subsidiaries using idle funds to purchase wealth management products
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the use of raised funds to increase capital for wholly-owned subsidiaries to implement fund-raising projects
Jinling Pharmaceutical: Jinling Pharmaceutical Co., Ltd. 2023 Financial Results Report
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on increasing the use of idle funds raised and own funds for cash management
Jinling Pharmaceutical: Summary table of non-operating capital occupation and other related capital transactions of Jinling Pharmaceutical Co., Ltd. in 2023
Jinling Pharmaceutical: Notice of Annual General Meeting of Shareholders
Jinling Pharmaceutical: Report of the Audit Committee of the Board of Directors of Jinling Pharmaceutical Co., Ltd. on the performance of supervisory duties by the accounting firm in 2023
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on the use of idle funds raised and own funds for cash management
Jinling Pharmaceutical: Announcement of Jinling Pharmaceutical Co., Ltd. on signing tripartite and quadripartite supervisory agreements to raise capital
Jinling Pharmaceutical: Legal Opinion of Jiangsu Taihe Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Jinling Pharmaceutical Co., Ltd.
No Data